drugset / Trial / NCT03951142
Imaging Perfusion Restrictions From Extracellular Solid Stress - An Open-label Losartan Study
RandomizedParallel-groupOpen-labelDiagnostic
Summary
An open-label, single institutional phase II trial of losartan in patients with primary and metastatic brain tumors with an individual stepped-wedge, randomized, assessor-blinded, dose-finding design on three indications.
Timeline
- Start
- 2019-10-01
- Primary completion
- 2024-10-01
- Completion
- 2024-12-31
Publications
- Lysvik EK, Tulipan AJ, Haakensen VD, Revheim MR, Emblem KE, Hjornevik T. Quantitative [18F]PSMA-1007 PET in Treatment Response Monitoring of Brain Metastases from Non-small Cell Lung Cancer. Mol Imaging Biol. 2026 Apr 23. doi: 10.1007/s11307-026-02104-w. Online ahead of print.
- Lysvik EK, Mikalsen LTG, Rootwelt-Revheim ME, Emblem KE, Hjornevik T. Optimization of Q.Clear reconstruction for dynamic 18F PET imaging. EJNMMI Phys. 2023 Oct 20;10(1):65. doi: 10.1186/s40658-023-00584-1.